1. Home
  2. ARQQ vs LEXX Comparison

ARQQ vs LEXX Comparison

Compare ARQQ & LEXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARQQ
  • LEXX
  • Stock Information
  • Founded
  • ARQQ 2017
  • LEXX 2004
  • Country
  • ARQQ United Kingdom
  • LEXX Canada
  • Employees
  • ARQQ N/A
  • LEXX N/A
  • Industry
  • ARQQ Computer Software: Prepackaged Software
  • LEXX Biotechnology: Pharmaceutical Preparations
  • Sector
  • ARQQ Technology
  • LEXX Health Care
  • Exchange
  • ARQQ Nasdaq
  • LEXX Nasdaq
  • Market Cap
  • ARQQ 173.1M
  • LEXX 25.8M
  • IPO Year
  • ARQQ N/A
  • LEXX N/A
  • Fundamental
  • Price
  • ARQQ $12.61
  • LEXX $1.45
  • Analyst Decision
  • ARQQ Strong Buy
  • LEXX Strong Buy
  • Analyst Count
  • ARQQ 1
  • LEXX 1
  • Target Price
  • ARQQ $52.00
  • LEXX $7.00
  • AVG Volume (30 Days)
  • ARQQ 331.5K
  • LEXX 127.7K
  • Earning Date
  • ARQQ 12-05-2024
  • LEXX 04-08-2025
  • Dividend Yield
  • ARQQ N/A
  • LEXX N/A
  • EPS Growth
  • ARQQ N/A
  • LEXX N/A
  • EPS
  • ARQQ N/A
  • LEXX N/A
  • Revenue
  • ARQQ $293,000.00
  • LEXX $496,923.00
  • Revenue This Year
  • ARQQ $1,818.77
  • LEXX $30.72
  • Revenue Next Year
  • ARQQ N/A
  • LEXX $31.85
  • P/E Ratio
  • ARQQ N/A
  • LEXX N/A
  • Revenue Growth
  • ARQQ N/A
  • LEXX 77.63
  • 52 Week Low
  • ARQQ $3.72
  • LEXX $1.15
  • 52 Week High
  • ARQQ $52.79
  • LEXX $6.85
  • Technical
  • Relative Strength Index (RSI)
  • ARQQ 33.98
  • LEXX 43.81
  • Support Level
  • ARQQ $11.04
  • LEXX $1.15
  • Resistance Level
  • ARQQ $13.30
  • LEXX $1.44
  • Average True Range (ATR)
  • ARQQ 1.37
  • LEXX 0.14
  • MACD
  • ARQQ 0.14
  • LEXX 0.01
  • Stochastic Oscillator
  • ARQQ 23.45
  • LEXX 58.82

About ARQQ Arqit Quantum Inc.

Arqit Quantum Inc is a cybersecurity company that has pioneered a symmetric key agreement technology that makes the communications links of any networked device or data at rest secure against current and future forms of cyber attack - even an attack from a quantum computer. The company delivers its symmetric key agreement technology via its product QuantumCloud. The firm operates in one segment that is, the provision of cybersecurity services via satellite and terrestrial platforms. The company operates and generates its revenue from UK.

About LEXX Lexaria Bioscience Corp.

Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH can increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood-brain barrier. The company has four reportable segments: Intellectual Property Licensing which generates maximum revenue, B2B Production, Research and Development, and Corporate. Geographically, it derives revenue from the United States and Canada.

Share on Social Networks: